Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin.

Srirangam A, Milani M, Mitra R, Guo Z, Rodriguez M, Kathuria H, Fukuda S, Rizzardi A, Schmechel S, Skalnik DG, Pelus LM, Potter DA.

J Thorac Oncol. 2011 Apr;6(4):661-70. doi: 10.1097/JTO.0b013e31820c9e3c.

2.

Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells.

Kumar S, Bryant CS, Chamala S, Qazi A, Seward S, Pal J, Steffes CP, Weaver DW, Morris R, Malone JM, Shammas MA, Prasad M, Batchu RB.

Mol Cancer. 2009 Apr 22;8:26. doi: 10.1186/1476-4598-8-26.

3.

Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer.

Srirangam A, Mitra R, Wang M, Gorski JC, Badve S, Baldridge L, Hamilton J, Kishimoto H, Hawes J, Li L, Orschell CM, Srour EF, Blum JS, Donner D, Sledge GW, Nakshatri H, Potter DA.

Clin Cancer Res. 2006 Mar 15;12(6):1883-96.

4.

The effects of combined treatment with sevoflurane and cisplatin on growth and invasion of human adenocarcinoma cell line A549.

Liang H, Wang HB, Liu HZ, Wen XJ, Zhou QL, Yang CX.

Biomed Pharmacother. 2013 Jul;67(6):503-9. doi: 10.1016/j.biopha.2013.03.005. Epub 2013 Mar 29.

PMID:
23639227
5.
6.

Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line.

Biliran H Jr, Wang Y, Banerjee S, Xu H, Heng H, Thakur A, Bollig A, Sarkar FH, Liao JD.

Clin Cancer Res. 2005 Aug 15;11(16):6075-86.

7.

Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias.

Tobin LA, Robert C, Rapoport AP, Gojo I, Baer MR, Tomkinson AE, Rassool FV.

Oncogene. 2013 Apr 4;32(14):1784-93. doi: 10.1038/onc.2012.203. Epub 2012 May 28.

8.

Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.

Dong X, Lin D, Low C, Vucic EA, English JC, Yee J, Murray N, Lam WL, Ling V, Lam S, Gout PW, Wang Y.

J Thorac Oncol. 2013 Feb;8(2):161-70. doi: 10.1097/JTO.0b013e31827d5237.

9.

Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation.

Sankpal UT, Ingersoll SB, Ahmad S, Holloway RW, Bhat VB, Simecka JW, Daniel L, Kariali E, Vishwanatha JK, Basha R.

Tumour Biol. 2016 Oct;37(10):14259-14269. Epub 2016 Aug 31.

PMID:
27581819
10.

PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells.

Cheng H, Zhang Z, Borczuk A, Powell CA, Balajee AS, Lieberman HB, Halmos B.

Carcinogenesis. 2013 Apr;34(4):739-49. doi: 10.1093/carcin/bgs393. Epub 2012 Dec 28.

11.

A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.

Lin L, Hutzen B, Li PK, Ball S, Zuo M, DeAngelis S, Foust E, Sobo M, Friedman L, Bhasin D, Cen L, Li C, Lin J.

Neoplasia. 2010 Jan;12(1):39-50.

12.

Influence of gefitinib and erlotinib on apoptosis and c-MYC expression in H23 lung cancer cells.

Suenaga M, Yamamoto M, Tabata S, Itakura S, Miyata M, Hamasaki S, Furukawa T.

Anticancer Res. 2013 Apr;33(4):1547-54.

PMID:
23564796
13.

siRNA directed against survivin enhances pancreatic cancer cell gemcitabine chemosensitivity.

Liu WS, Yan HJ, Qin RY, Tian R, Wang M, Jiang JX, Shen M, Shi CJ.

Dig Dis Sci. 2009 Jan;54(1):89-96. doi: 10.1007/s10620-008-0329-4. Epub 2008 Jul 2.

PMID:
18594980
14.

Arsenic trioxide inhibits the growth of human lung cancer cell lines via cell cycle arrest and induction of apoptosis at both normoxia and hypoxia.

Qu GP, Xiu QY, Li B, Liu YA, Zhang LZ.

Toxicol Ind Health. 2009 Sep;25(8):505-15. doi: 10.1177/0748233709345936.

PMID:
19825857
16.

siRNA-mediated silencing of survivin inhibits proliferation and enhances etoposide chemosensitivity in acute myeloid leukemia cells.

Karami H, Baradaran B, Esfahani A, Estiar MA, Naghavi-Behzad M, Sakhinia M, Sakhinia E.

Asian Pac J Cancer Prev. 2013;14(12):7719-24.

17.

Dickkopf-3 (Dkk3) induces apoptosis in cisplatin-resistant lung adenocarcinoma cells via the Wnt/β-catenin pathway.

Wang Z, Ma LJ, Kang Y, Li X, Zhang XJ.

Oncol Rep. 2015 Mar;33(3):1097-106. doi: 10.3892/or.2014.3704. Epub 2014 Dec 30.

PMID:
25573172
18.

MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.

Zarogoulidis P, Petanidis S, Kioseoglou E, Domvri K, Anestakis D, Zarogoulidis K.

Cell Signal. 2015 Aug;27(8):1576-88. doi: 10.1016/j.cellsig.2015.04.009. Epub 2015 Apr 25.

PMID:
25917317
20.

[Effect of trichostatin A and paclitaxel on the growth and apoptosis of lung adenocarcinoma cell lines].

Zhang S, Wang XA, Zhang QC, Jiang SJ.

Zhonghua Zhong Liu Za Zhi. 2012 Jul;34(7):492-6. doi: 10.3760/cma.j.issn.0253-3766.2012.07.004. Chinese.

PMID:
22967465

Supplemental Content

Support Center